crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 72817

Časopis

Autori: Sikirić, Predrag; Seiwerth, Sven; Aralica, Gorana; Perović, Darko; Starešinić, Mario; Anić, Tomislav; Gjurašin, Miroslav; Prkačin, Ingrid; Šeparović, Jadranka; Stančić-Rokotov, Dinko; Lovrić-Benčić, Martina; Mikuš, Darko; Turković, Branko; Rotkvić, Ivo; Miše, Stjepan; Ručman, Rudolf; Petek, Marijan; Žiger, Tihomil; Sebečić, Božidar; Ivasović, Zoran; Jagić, Vjekoslav; Komerički, Liljana; Balen, Ivica; Boban-Blagaić, Alenka; Sjekavica, Ivo
Naslov: Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat
( Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat )
Izvornik: Journal of Physiology-Paris 95 (2001); 283 - 288
Vrsta rada: članak
Ključne riječi: Cysteamine chronic colon lesions; Recidive; Pentadecapeptide BPC 157; Gastroduodenal antiulcer agents; Remedies for inflammatory bowel disease
( Cysteamine chronic colon lesions; Recidive; Pentadecapeptide BPC 157; Gastroduodenal antiulcer agents; Remedies for inflammatory bowel disease )
Sažetak:
After demonstration that cysteamine induced duodenal lesions in gastrectomized rats, while a number of antiulcer drugs mitigated these lesions, it was shown that one single intrarectal (i.r.) cysteamine application produced severe colon lesions in acute studies in rats. Thus, the further focus was on the protracted effect of cysteamine colon challenge (400 mg/kg b.w. i.r.) and therapy influence in chronic experiments in female rats. Regularly, cysteamine colon lesion were markedly mitigated by ranitidin (10), omeprazole (10), atropine (10), methylprednisolone (1), sulphasalazine (50 ; mg/kg), pentadecapeptide BPC 157 (PL-10, PLD-116 ; 10 microgram or 10 nanogram/kg). Specifically, after 1 or 3 months following initial challenge ( cysteamine 400 mg/kg i.r.) in female rat, the therapy ((BPC 157 (PL-10, PLD-116 (10.0 microgram or 10.0 nanogram/kg ; i.g., i.p., i.r.), ranitidine, omeprazole, atropine, methylpradnisolone, sulphasalazine (i.p.)) reversed the protracted cysteamine colon injury: the 1 week-regimen (once daily application) started after 1 month post-cysteamine, as well as the 2 weeks-regimen (once daily application), which started after 3 months. The effect on recidive lesio was also tasted. These cysteamine lesions may reappear after stopping therapy ( after stopping therapy for 3 weeks at the end of 2 weeks-regimen started i 3 month-cysteamine female rats) in sulphasalazine group, while this reappearance in markedly antagonized i pentadecapeptide BPC 157 (PL-10, PLD-116)-rats (cysteamine-colon lesion still substantially low).
Projekt / tema: 0108196
Izvorni jezik: eng
Rad je indeksiran u
bazama podataka:
Current Contents Connect (CCC)
SCI-EXP, SSCI i/ili A&HCI
Kategorija: Znanstveni
Znanstvena područja:
Temeljne medicinske znanosti
URL cjelovitog teksta:
Google Scholar: Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat



  Verzija za printanje   za tiskati


upomoc
foot_4